ABSTRACT - 598030 The disclosure relates to a composition comprising crystalline trans-(+-)-(9-tetrahydrocannabinol and a pharmaceutically-acceptable carrier, wherein said pharmaceutically-acceptable carriers can be solid or dry components or they can be liquids, such as water or oils, including those of petroleum, animal, vegetable or synthetic origin, such as peanut oil, soybean oil, mineral oil, sesame oil, and the like in which said tetrahydrocannabinol can be suspended said carriers can also be selected from saline, gum acacia, gelatin, starch paste, talc, keratin, colloidal silica, urea, and the like and wherein said composition can take the form of a suspension, tablet, pill, pellet, suppository, or capsule, (e.g., a capsule containing a powder, microparticles, multiparticulates, or nanoparticles) form or any other form suitable for use. These compositions are suitable for treating or preventing a condition such as, inter alia, pain, emesis, loss of appetite or weight loss.
